Clinical Trial Update: Raloxifene Augmentation in Patients With a Schizophrenia Spectrum Disorder [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating raloxifene augmentation in patients with schizophrenia-spectrum disorders has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psychosis Nos
• Schizoaffective Disorder
• Schizophrenia
• Schizophreniform Disorder

Drugs mentioned

• Raloxifene (raloxifene)

Snippet

Sponsor: Iris Sommer | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 3 | Status: COMPLETED